Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:EC 3.5.1.2 (glutaminase) inhibitor
go back to main search page
Accession:CHEBI:60280 term browser browse the term
Definition:Any EC 3.5.1.* (non-peptide linear amide C-N hydrolase) inhibitor that interferes with the activity of a glutaminase (EC 3.5.1.2) and thus the generation of glutamate from glutamine.
Synonyms:related_synonym: EC 3.5.1.2 inhibitor;   EC 3.5.1.2 inhibitors;   L-glutaminase inhibitor;   L-glutaminase inhibitors;   L-glutamine amidohydrolase inhibitor;   L-glutamine amidohydrolase inhibitors;   glutaminase (EC 3.5.1.2) inhibitors;   glutaminase I inhibitor;   glutaminase I inhibitors;   glutaminase inhibitor;   glutaminase inhibitors;   glutamine aminohydrolase inhibitor;   glutamine aminohydrolase inhibitors


show annotations for term's descendants           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19816
    role 19764
      biological role 19764
        biochemical role 19313
          enzyme inhibitor 18173
            EC 3.* (hydrolase) inhibitor 17665
              EC 3.5.* (hydrolases acting on non-peptide C-N bonds) inhibitor 17566
                EC 3.5.1.* (non-peptide linear amide C-N hydrolase) inhibitor 17566
                  EC 3.5.1.2 (glutaminase) inhibitor 0
                    5-[3-bromo-4-(dimethylamino)phenyl]-2,2-dimethyl-2,3,5,6-tetrahydrobenzo[a]phenanthridin-4(1H)-one 0
                    6-diazo-5-oxo-L-norleucine 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.